Neurotransmitters are chemical messengers that transmit signals between neurons. Several neurotransmitter systems have particularly important roles in cognition. Dopamine modulates reward processing, motivation, working memory, and learning from feedback. Acetylcholine supports attention, memory encoding, and cortical plasticity. Norepinephrine regulates arousal, attention, and stress responses. Serotonin influences mood, impulse control, and decision-making. GABA and glutamate are the primary inhibitory and excitatory neurotransmitters, respectively, governing the balance of neural activity.
Key Structures
- Ventral tegmental area & substantia nigra (dopamine)
- Basal forebrain (acetylcholine) — The basal forebrain cholinergic system that modulates cortical arousal, attention, and memory through widespread acetylcholine release.
- Raphe nuclei (serotonin) — Brainstem nuclei that produce serotonin, modulating mood, sleep, appetite, and impulse control across widespread brain regions.
- Locus coeruleus (norepinephrine) — The brainstem nucleus that is the primary source of norepinephrine, modulating arousal, attention, and stress responses.
- Prefrontal Cortex — The anterior portion of the frontal lobe, critical for executive functions including planning, decision-making, working memory, and cognitive control.
- Working Memory — A limited-capacity system for temporarily holding and manipulating information during complex cognitive tasks such as reasoning, comprehension, and learning.
- Rescorla-Wagner Model — A mathematical model of classical conditioning proposing that learning is driven by prediction error — the discrepancy between expected and actual outcomes.
Key Functions
Chemical messengers that transmit signals across synapses, with distinct neurotransmitter systems modulating specific cognitive functions: dopamine (reward, motivation, working memory), acetylcholine (attention, memory), serotonin (mood, impulse control), norepinephrine (arousal, vigilance).
Dopamine and Cognition
Dopamine plays a central role in reward-based learning through prediction error signals (see Rescorla-Wagner Model) and in working memory maintenance through D1 receptor activation in the prefrontal cortex. The inverted-U relationship between dopamine levels and prefrontal function means both too little (Parkinson's disease) and too much (schizophrenia) dopamine impair cognition. This principle has implications for pharmacological cognitive enhancement and for understanding why stimulant medications (which increase dopamine) help ADHD symptoms.
Understanding neurotransmitter-cognition relationships has fueled interest in cognitive enhancement. Cholinesterase inhibitors (donepezil) modestly slow cognitive decline in Alzheimer's disease. Modafinil may enhance executive function in sleep-deprived individuals. Methylphenidate and amphetamine improve attention in ADHD. However, cognitive enhancement in healthy individuals is modest and often accompanied by trade-offs (improving one function at the expense of another), reflecting the evolved optimization of neurotransmitter levels.
Disorders
- Parkinson's disease (dopamine loss) — Dopamine depletion causing motor symptoms (tremor, rigidity, bradykinesia) plus cognitive deficits in executive function, attention, and visuospatial skills.
- Alzheimer's disease (acetylcholine decline) — A progressive neurodegenerative disease characterized by memory loss, cognitive decline, and personality changes — the most common cause of dementia in older adults.
- Depression (serotonin/norepinephrine imbalance) — Mood disorder with pervasive sadness and anhedonia; cognitive symptoms include difficulty concentrating, memory problems, and negative cognitive biases.
- Schizophrenia (dopamine dysregulation) — Severe psychiatric disorder with hallucinations, delusions, and thought disorder; prominent cognitive deficits in memory, attention, and executive function.
- ADHD (dopamine/norepinephrine) — Attention-Deficit/Hyperactivity Disorder — a neurodevelopmental condition characterized by persistent patterns of inattention, hyperactivity, and impulsivity affecting cognitive functioning.